Viral load and B-catenin level correlation study in patients with chronic hepatitis B virus
Keywords:
viral hepatitis, autoimmune diseases, hepatitis B X protein (HBx), real time PCR, viral loadAbstract
Hepatitis a general term which refers to inflammation of the liver. It may result from various causes, both infectious ( viral, bacterial, fungal, and parasitic) and noninfectious (alcohol, drugs, autoimmune diseases, and metabolic diseases). The hepatitis B X protein (HBx) plays a role in the epigenetic regulation of HBV replication. Real-time PCR has catalysed wider acceptance of PCR because it is more rapid, sensitive and reproducible, while the risk of carryover contamination is minimised. The present study is a case-control study design comprise a total of 58 patient with hepatitis B of which 29 patients were with chronic infection and additional 29 patient with chronic hepatitis, and 30 apparently healthy control subjects. In the current study, fifty - eight diagnosed hepatitis B virus patients were enrolled. The correlations of study biomarkers with viral load in the (chronic hepatitis group) of HBV patients. B-catenin showed a significant positive correlation with viral load in chronic hepatitis group (r = 0.387, p = 0.038).
Downloads
References
Yoshiaki Yasutake, Shin-ichiro Hattori, Noriko Tamura, Kouki Matsuda, Satoru Kohgo, Kenji Maeda & Hiroaki Mitsuya . Structural features in common of HBV and HIV-1 resistance against chirally-distinct nucleoside analogues entecavir and lamivudine Sci Rep 10, 3021 (2020).
Ott JJ, Horn J, Krause G, Mikolajczyk RT. Time trends of chronic HBV infection over prior decades – A global analysis. J Hepatol 2017;66:48–54.
Schillie S, Vellozzi C, Reingold A, et al. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. (2018).
Vijay Kumar1 , Saumitra Das and Shahid Jameel The biology and pathogenesis of hepatitis viruses VOL. 98, NO. 3, 10 FEBRUARY (2018) .
Papatheodoridis GV, Cornberg M, Xie Q, Lampertico P, Burghaus I, Bakalos G, et al. Incidence and risk prediction of hepatocellular carcinoma: retrospective analysis of the S-collate study. Hepatol Int 2017;11:S4–S5.
Mathilde Dusséaux , Guillemette Masse - Ranson , Sylvie Darche , James Ahodantin , Yan Li, Oriane Fiquet, Elodie Beaumont, Pierrick Moreau, Lise Rivière, Christine Neuveut, Patrick Soussan, Philippe Roingeard, Dina Kremsdorf, James P. Di Santo, and Helene Strick-Marchand , Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver , 2017 Dec; 153(6): 1647–1661.
Rene Jackstadt, Michael Charles Hodder, and Owen James Sansom , WNT and beta catenin in cancer , 2020 .
Varma Kachnar, Chauhan Aprajita, Bhargava Mudita, Misra Vatsala, Srivastava Sapan , Association of different patterns of expression of beta-catenin and cyclin D1 with pathogenesis of breast carcinoma , Year : 2020 | Volume: 63 | Issue Number: 1 | Page: 13-18.
Wong, R.J.; Jain, M.K.; Therapondos, G.; Niu, B.; Kshirsagar, O.; Thamer, M. Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems. Am. J. Gastroenterol. 2021.
Liu, C., Chang, L., Jia, T. et al. Real-time PCR assays for hepatitis B virus DNA quantification may require two different targets. Virol J 14, 94 (2017).
Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: A systematic review of data published between 1965 and 2013. Lancet (2015);386:1546–1555
von Olshausen G, Quasdorff M, Bester R, et al. Hepatitis B virus promotes β-catenin-signalling and disassembly of adherens junctions in a Src kinase dependent fashion. Oncotarget ;9(74):33947-33960. 2018.
Tarnow G, McLachlan A. β-catenin Signaling Regulates the In Vivo Distribution of Hepatitis B Virus Biosynthesis across the Liver Lobule. J Virol. 27;95(20):e0078021. 2021.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.